A Phase 2 Trial of Radium Ra 223 Dichloride in Combination With Androgen Deprivation Therapy and Stereotactic Body Radiation Therapy for Patients With Oligometastatic Castration Sensitive Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2019
Price : $35 *
At a glance
- Drugs Radium 223 chloride (Primary) ; Goserelin; Leuprorelin; Leuprorelin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 25 Nov 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 25 Nov 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 31 Aug 2018 Biomarkers information updated